Immunomodulatory Effect of the Bacillus Calmette–Guérin (BCG) Vaccine on the In Vitro Interferon Response Induced by Respiratory Syncytial Virus (RSV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigens

Abarca K, Rey-Jurado E, Muñoz-Durango N et al. (2020) Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial. EClinicalMedicine 27:100517. https://doi.org/10.1016/j.eclinm.2020.100517 AbarcaK Rey-JuradoE Muñoz-DurangoN 2020 Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial EClinicalMedicine 27 100517 https://doi.org/10.1016/j.eclinm.2020.100517 Search in Google Scholar

Aberle JH, Aberle SW, Dworzak MN et al. (1999) Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease. Am J Respir Crit Care Med 160:1263–1268. https://doi.org/10.1164/ajrccm.160.4.9812025 AberleJH AberleSW DworzakMN 1999 Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease Am J Respir Crit Care Med 160 1263 1268 https://doi.org/10.1164/ajrccm.160.4.9812025 Search in Google Scholar

Akter S, Roy AS, Tonmoy MIQ et al. (2022) Deleterious single nucleotide polymorphisms (SNPs) of human IFNAR2 gene facilitate COVID-19 severity in patients: a comprehensive in silico approach. J Biomol Struct Dyn 40:11173–11189. https://doi.org/10.1080/07391102.2021.1957714 AkterS RoyAS TonmoyMIQ 2022 Deleterious single nucleotide polymorphisms (SNPs) of human IFNAR2 gene facilitate COVID-19 severity in patients: a comprehensive in silico approach J Biomol Struct Dyn 40 11173 11189 https://doi.org/10.1080/07391102.2021.1957714 Search in Google Scholar

Antunes KH, Fachi JL, de Paula R et al. (2019) Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response. Nat Commun 10:3273. https://doi.org/10.1038/s41467-019-11152-6 AntunesKH FachiJL de PaulaR 2019 Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response Nat Commun 10 3273 https://doi.org/10.1038/s41467-019-11152-6 Search in Google Scholar

Arts RJ, Blok BA, Aaby P et al. (2015) Long-term in vitro and in vivo effects of γ-irradiated BCG on innate and adaptive immunity. J Leukoc Biol 98:995–1001. https://doi.org/10.1189/jlb.4ma0215-059R ArtsRJ BlokBA AabyP 2015 Long-term in vitro and in vivo effects of γ-irradiated BCG on innate and adaptive immunity J Leukoc Biol 98 995 1001 https://doi.org/10.1189/jlb.4ma0215-059R Search in Google Scholar

Arts RJW, Carvalho A, La Rocca C et al. (2016) Immunometabolic pathways in BCG-induced trained immunity. Cell Rep 17:2562–2571. https://doi.org/10.1016/j.celrep.2016.11.011 ArtsRJW CarvalhoA La RoccaC 2016 Immunometabolic pathways in BCG-induced trained immunity Cell Rep 17 2562 2571 https://doi.org/10.1016/j.celrep.2016.11.011 Search in Google Scholar

Arts RJW, Moorlag SJCFM, Novakovic B et al. (2018) BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity. Cell Host Microbe 23:89–100.e5. https://doi.org/10.1016/j.chom.2017.12.010 ArtsRJW MoorlagSJCFM NovakovicB 2018 BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity Cell Host Microbe 23 89 100.e5 https://doi.org/10.1016/j.chom.2017.12.010 Search in Google Scholar

Bessière P, Wasniewski M, Picard-Meyer E et al. (2021) Intranasal type I interferon treatment is beneficial only when administered before clinical signs onset in the SARS-CoV-2 hamster model. PLoS Pathog 17:e1009427. https://doi.org/10.1371/journal.ppat.1009427 BessièreP WasniewskiM Picard-MeyerE 2021 Intranasal type I interferon treatment is beneficial only when administered before clinical signs onset in the SARS-CoV-2 hamster model PLoS Pathog 17 e1009427 https://doi.org/10.1371/journal.ppat.1009427 Search in Google Scholar

Beyer DK, Forero A (2022) Mechanisms of antiviral immune evasion of SARS-CoV-2. J Mol Biol 434:167265. https://doi.org/10.1016/j.jmb.2021.167265 BeyerDK ForeroA 2022 Mechanisms of antiviral immune evasion of SARS-CoV-2 J Mol Biol 434 167265 https://doi.org/10.1016/j.jmb.2021.167265 Search in Google Scholar

Biering-Sørensen S, Aaby P, Napirna BM et al. (2012) Small randomized trial among low-birth-weight children receiving bacillus Calmette–Guérin vaccination at first health center contact. Pediatr Infect Dis J 31:306–308. https://doi.org/10.1097/INF.0B013E3182458289 Biering-SørensenS AabyP NapirnaBM 2012 Small randomized trial among low-birth-weight children receiving bacillus Calmette–Guérin vaccination at first health center contact Pediatr Infect Dis J 31 306 308 https://doi.org/10.1097/INF.0B013E3182458289 Search in Google Scholar

Blasius AL, Beutler B (2010) Intracellular toll-like receptors. Immunity 32:305–315. https://doi.org/10.1016/j.immuni.2010.03.012 BlasiusAL BeutlerB 2010 Intracellular toll-like receptors Immunity 32 305 315 https://doi.org/10.1016/j.immuni.2010.03.012 Search in Google Scholar

Bont L, Heijnen CJ, Kavelaars A et al. (2001) Local interferon-gamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity. J Infect Dis 184:355–358. https://doi.org/10.1086/322035 BontL HeijnenCJ KavelaarsA 2001 Local interferon-gamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity J Infect Dis 184 355 358 https://doi.org/10.1086/322035 Search in Google Scholar

Chen J, Liu J, Chen Z et al. (2022) Angiotensin-converting enzyme 2 potentiates SARS-CoV-2 infection by antagonizing type I interferon induction and its down-stream signaling pathway. mSphere 7:e0021122. https://doi.org/10.1128/msphere.00211-22 ChenJ LiuJ ChenZ 2022 Angiotensin-converting enzyme 2 potentiates SARS-CoV-2 infection by antagonizing type I interferon induction and its down-stream signaling pathway mSphere 7 e0021122 https://doi.org/10.1128/msphere.00211-22 Search in Google Scholar

Chong Z, Karl CE, Halfmann PJ et al. (2022) Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron. Cell Rep 39:110799. https://doi.org/10.1016/j.celrep.2022.110799 ChongZ KarlCE HalfmannPJ 2022 Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron Cell Rep 39 110799 https://doi.org/10.1016/j.celrep.2022.110799 Search in Google Scholar

Corral-Fernández NE, Cortez-Espinosa N, Salgado-Bustamante M et al. (2016) Induction of transcription factors, miRNAs and cytokines involved in T lymphocyte differentiation in BCG-vaccinated subjects. Mol Immunol 77:44–51. https://doi.org/10.1016/j.molimm.2016.07.006 Corral-FernándezNE Cortez-EspinosaN Salgado-BustamanteM 2016 Induction of transcription factors, miRNAs and cytokines involved in T lymphocyte differentiation in BCG-vaccinated subjects Mol Immunol 77 44 51 https://doi.org/10.1016/j.molimm.2016.07.006 Search in Google Scholar

Díaz FE, Guerra-Maupome M, McDonald PO et al. (2021) A recombinant BCG vaccine is safe and immunogenic in neonatal calves and reduces the clinical disease caused by the respiratory syncytial virus. Front Immunol 12:664212. https://doi.org/10.3389/fimmu.2021.664212 DíazFE Guerra-MaupomeM McDonaldPO 2021 A recombinant BCG vaccine is safe and immunogenic in neonatal calves and reduces the clinical disease caused by the respiratory syncytial virus Front Immunol 12 664212 https://doi.org/10.3389/fimmu.2021.664212 Search in Google Scholar

Eichinger KM, Egaña L, Orend JG et al. (2015) Alveolar macrophages support interferon gamma-mediated viral clearance in RSV-infected neonatal mice. Respir Res 16:122. https://doi.org/10.1186/S12931-015-0282-7 EichingerKM EgañaL OrendJG 2015 Alveolar macrophages support interferon gamma-mediated viral clearance in RSV-infected neonatal mice Respir Res 16 122 https://doi.org/10.1186/S12931-015-0282-7 Search in Google Scholar

Faustman DL, Lee A, Hostetter ER et al. (2022) Multiple BCG vaccinations for the prevention of COVID-19 and other infectious diseases in type 1 diabetes. Cell Rep Med 3:100728. https://doi.org/10.1016/j.xcrm.2022.100728 FaustmanDL LeeA HostetterER 2022 Multiple BCG vaccinations for the prevention of COVID-19 and other infectious diseases in type 1 diabetes Cell Rep Med 3 100728 https://doi.org/10.1016/j.xcrm.2022.100728 Search in Google Scholar

Hijano DR, Vu LD, Kauvar LM et al. (2019) Role of type I interferon (IFN) in the respiratory syncytial virus (RSV) immune response and disease severity. Front Immunol 10:566. https://doi.org/10.3389/fimmu.2019.00566 HijanoDR VuLD KauvarLM 2019 Role of type I interferon (IFN) in the respiratory syncytial virus (RSV) immune response and disease severity Front Immunol 10 566 https://doi.org/10.3389/fimmu.2019.00566 Search in Google Scholar

Hilligan KL, Namasivayam S, Clancy CS et al. (2022) Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge. J Exp Med 219:e20211862. https://doi.org/10.1084/jem.20211862 HilliganKL NamasivayamS ClancyCS 2022 Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge J Exp Med 219 e20211862 https://doi.org/10.1084/jem.20211862 Search in Google Scholar

Hilligan KL, Namasivayam S, Clancy CS et al. (2023) Bacterial-induced or passively administered interferon gamma conditions the lung for early control of SARS-CoV-2. Nat Commun 14:8229. https://doi.org/10.1038/s41467-023-43447-0 HilliganKL NamasivayamS ClancyCS 2023 Bacterial-induced or passively administered interferon gamma conditions the lung for early control of SARS-CoV-2 Nat Commun 14 8229 https://doi.org/10.1038/s41467-023-43447-0 Search in Google Scholar

Kaufmann E, Khan N, Tran KA et al. (2022) BCG vaccination provides protection against IAV but not SARS-CoV-2. Cell Rep 38:110502. https://doi.org/10.1016/j.celrep.2022.110502 KaufmannE KhanN TranKA 2022 BCG vaccination provides protection against IAV but not SARS-CoV-2 Cell Rep 38 110502 https://doi.org/10.1016/j.celrep.2022.110502 Search in Google Scholar

Kaufmann E, Sanz J, Dunn JL et al. (2018) BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis. Cell 172:176–190.e19. https://doi.org/10.1016/j.cell.2017.12.031 KaufmannE SanzJ DunnJL 2018 BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis Cell 172 176 190.e19 https://doi.org/10.1016/j.cell.2017.12.031 Search in Google Scholar

Kaur BP, Secord E (2021) Innate immunity. Immunol Allergy Clin North Am 41:535–541. https://doi.org/10.1016/j.iac.2021.07.003 KaurBP SecordE 2021 Innate immunity Immunol Allergy Clin North Am 41 535 541 https://doi.org/10.1016/j.iac.2021.07.003 Search in Google Scholar

Kleinnijenhuis J, Quintin J, Preijers F et al. (2012) Bacille Calmette–Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci USA 109:17537–17542. https://doi.org/10.1073/PNAS.1202870109 KleinnijenhuisJ QuintinJ PreijersF 2012 Bacille Calmette–Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes Proc Natl Acad Sci USA 109 17537 17542 https://doi.org/10.1073/PNAS.1202870109 Search in Google Scholar

Kleinnijenhuis J, Quintin J, Preijers F et al. (2014) Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity. J Innate Immun 6:152–158. https://doi.org/10.1159/000355628 KleinnijenhuisJ QuintinJ PreijersF 2014 Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity J Innate Immun 6 152 158 https://doi.org/10.1159/000355628 Search in Google Scholar

Lalor MK, Floyd S, Gorak-Stolinska P et al. (2011) BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and Malawi. J Infect Dis 204:1075–1085. https://doi.org/10.1093/infdis/jir515 LalorMK FloydS Gorak-StolinskaP 2011 BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and Malawi J Infect Dis 204 1075 1085 https://doi.org/10.1093/infdis/jir515 Search in Google Scholar

Lalor MK, Smith SG, Floyd S et al. (2010) Complex cytokine profiles induced by BCG vaccination in UK infants. Vaccine 28:1635–1641. https://doi.org/10.1016/j.vaccine.2009.11.004 LalorMK SmithSG FloydS 2010 Complex cytokine profiles induced by BCG vaccination in UK infants Vaccine 28 1635 1641 https://doi.org/10.1016/j.vaccine.2009.11.004 Search in Google Scholar

Leentjens J, Kox M, Stokman R et al. (2015) BCG vaccination enhances the immunogenicity of subsequent influenza vaccination in healthy volunteers: a randomized, placebo-controlled pilot study. J Infect Dis 212:1930–1938. https://doi.org/10.1093/infdis/jiv332 LeentjensJ KoxM StokmanR 2015 BCG vaccination enhances the immunogenicity of subsequent influenza vaccination in healthy volunteers: a randomized, placebo-controlled pilot study J Infect Dis 212 1930 1938 https://doi.org/10.1093/infdis/jiv332 Search in Google Scholar

Li JY, Liao CH, Wang Q et al. (2020) The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway. Virus Res 286:198074. https://doi.org/10.1016/j.virusres.2020.198074 LiJY LiaoCH WangQ 2020 The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway Virus Res 286 198074 https://doi.org/10.1016/j.virusres.2020.198074 Search in Google Scholar

Liu BM, Li NL, Wang R et al. (2024a) Key roles for phosphorylation and the Coiled-coil domain in TRIM56-mediated positive regulation of TLR3-TRIF–dependent innate immunity. J Biol Chem 300:107249. https://doi.org/10.1016/j.jbc.2024.107249 LiuBM LiNL WangR 2024a Key roles for phosphorylation and the Coiled-coil domain in TRIM56-mediated positive regulation of TLR3-TRIF–dependent innate immunity J Biol Chem 300 107249 https://doi.org/10.1016/j.jbc.2024.107249 Search in Google Scholar

Liu BM, Rakhmanina NY, Yang Z et al. (2024b) Mpox (Monkeypox) virus and its co-infection with HIV, sexually transmitted infections, or bacterial superinfections: double whammy or a new prime culprit? Viruses 16:784. https://doi.org/10.3390/V16050784 LiuBM RakhmaninaNY YangZ 2024b Mpox (Monkeypox) virus and its co-infection with HIV, sexually transmitted infections, or bacterial superinfections: double whammy or a new prime culprit? Viruses 16 784 https://doi.org/10.3390/V16050784 Search in Google Scholar

Lo MS, Brazas RM, Holtzman MJ (2005) Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J Virol 79:9315–9319. https://doi.org/10.1128/JVI.79.14.9315-9319.2005 LoMS BrazasRM HoltzmanMJ 2005 Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness J Virol 79 9315 9319 https://doi.org/10.1128/JVI.79.14.9315-9319.2005 Search in Google Scholar

Marr N, Wang TI, Kam SH et al. (2014) Attenuation of respiratory syncytial virus-induced and RIG-I-dependent type I IFN responses in human neonates and very young children. J Immunol 192:948–957. https://doi.org/10.4049/jimmunol.1302007 MarrN WangTI KamSH 2014 Attenuation of respiratory syncytial virus-induced and RIG-I-dependent type I IFN responses in human neonates and very young children J Immunol 192 948 957 https://doi.org/10.4049/jimmunol.1302007 Search in Google Scholar

Mitroulis I, Ruppova K, Wang B et al. (2018) Modulation of myelopoiesis progenitors is an integral component of trained immunity. Cell 172:147–161.e12. https://doi.org/10.1016/J.cell.2017.11.034 MitroulisI RuppovaK WangB 2018 Modulation of myelopoiesis progenitors is an integral component of trained immunity Cell 172 147 161.e12 https://doi.org/10.1016/J.cell.2017.11.034 Search in Google Scholar

Moorlag SJCFM, Arts RJW, van Crevel R et al. (2019) Non-specific effects of BCG vaccine on viral infections. Clin Microbiol Infect 25:1473–1478. https://doi.org/10.1016/j.cmi.2019.04.020 MoorlagSJCFM ArtsRJW van CrevelR 2019 Non-specific effects of BCG vaccine on viral infections Clin Microbiol Infect 25 1473 1478 https://doi.org/10.1016/j.cmi.2019.04.020 Search in Google Scholar

Mukherjee S, Subramaniam R, Chen H et al. (2017) Boosting efferocytosis in alveolar space using BCG vaccine to protect host against influenza pneumonia. PLoS One 12:e0180143. https://doi.org/10.1371/journal.pone.0180143 MukherjeeS SubramaniamR ChenH 2017 Boosting efferocytosis in alveolar space using BCG vaccine to protect host against influenza pneumonia PLoS One 12 e0180143 https://doi.org/10.1371/journal.pone.0180143 Search in Google Scholar

Netea MG, Quintin J, Van Der Meer JWM (2011) Trained immunity: a memory for innate host defense. Cell Host Microbe 9:355–361. https://doi.org/10.1016/j.chom.2011.04.006 NeteaMG QuintinJ Van Der MeerJWM 2011 Trained immunity: a memory for innate host defense Cell Host Microbe 9 355 361 https://doi.org/10.1016/j.chom.2011.04.006 Search in Google Scholar

Nguyen LS, Ait Hamou Z, Gastli N et al. (2021) Potential role for interferon gamma in the treatment of recurrent ventilator-acquired pneumonia in patients with COVID-19: a hypothesis. Intensive Care Med 47:619–621. https://doi.org/10.1007/S00134-021-06377-3 NguyenLS Ait HamouZ GastliN 2021 Potential role for interferon gamma in the treatment of recurrent ventilator-acquired pneumonia in patients with COVID-19: a hypothesis Intensive Care Med 47 619 621 https://doi.org/10.1007/S00134-021-06377-3 Search in Google Scholar

Ogger PP, Garcia Martín M, Michalaki C et al. (2022) Type I interferon receptor signalling deficiency results in dysregulated innate immune responses to SARS-CoV-2 in mice. Eur J Immunol 52:1768–1775. https://doi.org/10.1002/eji.202249913 OggerPP Garcia MartínM MichalakiC 2022 Type I interferon receptor signalling deficiency results in dysregulated innate immune responses to SARS-CoV-2 in mice Eur J Immunol 52 1768 1775 https://doi.org/10.1002/eji.202249913 Search in Google Scholar

Ramaswamy M, Shi L, Varga SM et al. (2006) Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. Virology 344:328–339. https://doi.org/10.1016/j.virol.2005.09.009 RamaswamyM ShiL VargaSM 2006 Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction Virology 344 328 339 https://doi.org/10.1016/j.virol.2005.09.009 Search in Google Scholar

Sir Karakus G, Tastan C, Dilek Kancagi D et al. (2021) Preclinical efficacy and safety analysis of gamma-irradiated inactivated SARS-CoV-2 vaccine candidates. Sci Rep 11:5804. https://doi.org/10.1038/S41598-021-83930-6 Sir KarakusG TastanC Dilek KancagiD 2021 Preclinical efficacy and safety analysis of gamma-irradiated inactivated SARS-CoV-2 vaccine candidates Sci Rep 11 5804 https://doi.org/10.1038/S41598-021-83930-6 Search in Google Scholar

Starr SE, Visintine AM, Tomeh MO et al. (1976) Effects of immunostimulants on resistance of newborn mice to herpes simplex type 2 infection. Proc Soc Exp Biol Med 152:57–60. https://doi.org/10.3181/00379727-152-39327 StarrSE VisintineAM TomehMO 1976 Effects of immunostimulants on resistance of newborn mice to herpes simplex type 2 infection Proc Soc Exp Biol Med 152 57 60 https://doi.org/10.3181/00379727-152-39327 Search in Google Scholar

Stensballe LG, Nante E, Jensen IP et al. (2005) Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case-control study. Vaccine 23:1251–1257. https://doi.org/10.1016/j.vaccine.2004.09.006 StensballeLG NanteE JensenIP 2005 Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls community based case-control study Vaccine 23 1251 1257 https://doi.org/10.1016/j.vaccine.2004.09.006 Search in Google Scholar

Sviridov D, Miller YI, Bukrinsky MI (2022) Trained immunity and HIV infection. Front Immunol 13:903884. https://doi.org/10.3389/fimmu.2022.903884 SviridovD MillerYI BukrinskyMI 2022 Trained immunity and HIV infection Front Immunol 13 903884 https://doi.org/10.3389/fimmu.2022.903884 Search in Google Scholar

Thieme CJ, Anft M, Paniskaki K et al. (2020) Robust T cell response toward spike, membrane, and nucleocapsid SARS-CoV-2 proteins is not associated with recovery in critical COVID-19 patients. Cell Rep Med 1:100092. https://doi.org/10.1016/j.xcrm.2020.100092 ThiemeCJ AnftM PaniskakiK 2020 Robust T cell response toward spike, membrane, and nucleocapsid SARS-CoV-2 proteins is not associated with recovery in critical COVID-19 patients Cell Rep Med 1 100092 https://doi.org/10.1016/j.xcrm.2020.100092 Search in Google Scholar

Uthayakumar D, Paris S, Chapat L et al. (2018) Non-specific effects of vaccines illustrated through the BCG example: from observations to demonstrations. Front Immunol 9:100092. https://doi.org/10.3389/fimmu.2018.02869 UthayakumarD ParisS ChapatL 2018 Non-specific effects of vaccines illustrated through the BCG example: from observations to demonstrations Front Immunol 9 100092 https://doi.org/10.3389/fimmu.2018.02869 Search in Google Scholar

van Laarhoven A, Kurver L, Overheul GJ et al. (2021) Interferon gamma immunotherapy in five critically ill COVID-19 patients with impaired cellular immunity: a case series. Med 2:1163–1170.e2. https://doi.org/10.1016/j.medj.2021.09.003 van LaarhovenA KurverL OverheulGJ 2021 Interferon gamma immunotherapy in five critically ill COVID-19 patients with impaired cellular immunity: a case series Med 2 1163 1170.e2 https://doi.org/10.1016/j.medj.2021.09.003 Search in Google Scholar

Vanderheiden A, Ralfs P, Chirkova T et al. (2020) Type I and Type III interferons restrict SARS-CoV-2 infection of human airway epithelial cultures. J Virol 94:e985–e920. https://doi.org/10.1128/JVI.00985-20 VanderheidenA RalfsP ChirkovaT 2020 Type I and Type III interferons restrict SARS-CoV-2 infection of human airway epithelial cultures J Virol 94 e985 e920 https://doi.org/10.1128/JVI.00985-20 Search in Google Scholar

Weir RE, Black GF, Nazareth B et al. (2006) The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette–Guérin vaccination in southern England and northern Malawi. Clin Exp Immunol 146:390–399. https://doi.org/10.1111/J.1365-2249.2006.03222.X WeirRE BlackGF NazarethB 2006 The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette–Guérin vaccination in southern England and northern Malawi Clin Exp Immunol 146 390 399 https://doi.org/10.1111/J.1365-2249.2006.03222.X Search in Google Scholar

Znaidia M, Demeret C, van der Werf S et al. (2022) Characterization of SARS-CoV-2 evasion: interferon pathway and therapeutic options. Viruses 14:1247. https://doi.org/10.3390/V14061247 ZnaidiaM DemeretC van der WerfS 2022 Characterization of SARS-CoV-2 evasion: interferon pathway and therapeutic options Viruses 14 1247 https://doi.org/10.3390/V14061247 Search in Google Scholar